4,000
Participants
Start Date
October 1, 2023
Primary Completion Date
September 30, 2027
Study Completion Date
December 31, 2027
prognosis status
observatory; patients will be divided into survival group and mortality group according to their prognosis at day 28
Ruijin Hospital
OTHER